Definiens is the leader in automated image analysis for life sciences and digital pathology. Our mission is to enable researchers and pathologists to discover and deliver new ways to impact science and healthcare by harnessing the power of our unique Cognition Network Technology®. We are headquartered in Munich, Germany with a North American office in Carlsbad, California.
Definiens has introduced its Tissue Studio 2.0, the latest version of the companys image analysis software for digital pathology and biomarker translational research
Definiens has launched version 2.0 of its LymphExpert software, a software application that assists radiology professionals in the identification, analysis and evaluation of lymph nodes in CT images over time
Definiens has introduced Definiens Tissue Studio, a digital pathology image analysis software package for translational biomarker research
Definiens has released a computer-aided detection (CAD) application that allows radiologists to identify and analyse lymph nodes volumetrically and compare them over time.
Definiens has released the latest version of its image analysis application Definiens TissueMap 3.0.
Definiens has released a multi-dimensional image analysis platform called Definiens XD.
Definiens has released Definiens TissueMap 2.0 for oncology research. The image analysis software application provides detailed, automated morphometric quantification of biomarkers of nuclei or cell bodies in epithelial tumours or xenografts.
Definiens has released the Definiens Enterprise Image Intelligence Suite 7. The latest version of the powerful image analysis platform provides life science organisations with improved data management capabilities.
Robert Roe interviews MathWorks Loren Dean, on the use of AI in modelling and simulation
Every device needs to work seamlessly in its operating environment. But when that environment is a human body, things get complicated.
Christian Marcazzo, general manager at IDBS, highlights trends in life sciences research and development.
Data is a company’s biggest asset, yet for any organisation, keeping a handle on the potentially vast volumes and diversity of data that are generated can represent a considerable issue.
Rob Lalonde, Univa’s cloud VP general manager, considers the unique challenges posed by HPC
Deep learning has seen a huge rise in popularity over the last five years in both enterprise and scientific applications.
HPC users are increasingly turning to cloud technologies due to their flexibility and scalability, allowing them to quickly change the size of their workloads, adopt new technologies in a small testing environment and to help to increase the agility of a company working across multiple sites, or
